Reckitt Benckiser shares technical analysis: Consolidation near GBX5,333 resistance as momentum turns mixed

Reckitt Benckiser shares technical analysis: Consolidation near GBX5,333 resistance as momentum turns mixed
Reckitt Benckiser gains 0.77% to GBX5,264

Reckitt Benckiser (RKT) stock is trading at GBX5,264, recording a modest gain for the session. The price sits above its principal short- and long-term moving averages but remains below intermediate-term levels.

RKT price prediction
24H 0.78%
GBX 5,643.5
48H 1.21%
GBX 5,667.5
7D 1.87%
GBX 5,704.5
1M 8.39%
GBX 6,070
3M -5.2%
GBX 5,308.98
6M -17.84%
GBX 4,600.76
12M -22.11%
GBX 4,362.03
Current price: GBX 5,600 22.00 0.39%
Real-time Data 13:26
Daily range 5564.00 Arrow from to Icon 5612.00
Weekly range 5442.00 Arrow from to Icon 5748.00
Loading...

Highlights

  • Reckitt Benckiser reported 3.3% core like-for-like revenue growth in the third quarter and cut its full-year sales outlook due to manufacturing constraints and soft demand in China.
  • The company completed £90 million of its planned £500 million share buyback by October 23, 2026, returning capital to shareholders.
  • Shares of Reckitt Benckiser face mixed technical signals, with a 57% probability of a move lower within a GBX5,012 to GBX5,515 range in the coming days.

Sales outlook cut as share buybacks offset mixed demand

Reckitt Benckiser reported 3.3% growth in core like-for-like revenue for the third quarter, highlighting underlying demand and operational momentum in its latest results, according to News Europawire. The company also completed £90 million of a planned £500 million share buyback by October 23, 2026, actively returning capital to shareholders and reducing available float. However, a cut to the full-year sales outlook—driven by manufacturing constraints affecting Lysol products in North America and weaker demand in China's vitamins, minerals and supplements business—signals challenges in key markets, as noted by Bbntimes.

Reckitt Benckiser asset chart
Reckitt Benckiser price dynamics. Source: TradingView.

Resistance narrows as momentum signals diverge

On the hourly chart, RKT remains above its MA-20 and the daily MA-200, but trades below the MA-50. Immediate upside is capped by the Ichimoku Kijun at GBX5,333, which serves as the closest resistance. Momentum indicators are mixed: MACD and ADX point to intraday downside pressure, while RSI stays in the sell zone. However, Stochastic RSI and Bull/Bear Power both show overbought signals, and CCI reads as neutral, indicating a divergence in short-term sentiment and moderate volatility conditions.

Downside risk dominates as support faces pressure

Over the coming trading sessions, RKT is expected to consolidate within a volatility band ranging from GBX5,012 to GBX5,515. Scenario analysis suggests a 57% probability of a downward move versus a 43% chance of an upward breakout. A bullish scenario would be triggered if price clears the GBX5,333 resistance, but failure to hold current support levels could tilt the risk toward further declines within the projected range.

Viktoras Karapetjanc, expert at Traders Union, believes Reckitt Benckiser’s resilient revenue growth and proactive share buyback underpin solid fundamental strength. He sees room for further upside if operational momentum persists and macro sentiment stabilizes. Near-term consolidation is likely, but constructive news flow and strong capital returns limit downside risks. "A break above GBX5,333 could unlock renewed buying interest, and I see recent results as a foundation for cautious optimism in the sessions ahead."

Earlier, analysts noted that Reckitt Benckiser faced mixed technical momentum and persistent operational headwinds, leading to a cautious outlook for sustained gains. The current analysis adds that continued consolidation within well-defined technical boundaries remains the prevailing scenario, making a close watch on the GBX5,333 resistance level essential for anticipating any directional shift.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.